The New York Medical Marijuana Program has struggled with low doctor and patient enrollment, but the addition of chronic pain as a qualifying condition has brought thousands of new patients into the program, and the state is gearing up for expansion.
On Aug. 1, 2017, the NYSDOH announced that it had approved five more registered organizations for the New York Medical Marijuana Program, with each registered organization permitted to cultivate and dispense medical marijuana in the state.
“The New York State Department of Health is committed to growing the state’s Medical Marijuana Program responsibly,” said Dr. Howard Zucker, New York State Department of Health Commissioner. “The addition of these registered organizations will make it easier for patients across the state to obtain medical marijuana, improve the affordability of medical marijuana products through the introduction of new competition, and increase the variety of medical marijuana products available to patients.”
Here are the five new licensees:
- Citiva Medical – manufacturing will be based in Orange County and dispensing facilities will be located in Chemung, Dutchess, Kings and Richmond Counties. Citiva unsuccessfully applied for Louisiana State University’s medical cannabis cultivation contract, but it recently applied for Southern University’s cultivation contract. Citiva has also applied for a cultivation license in Maryland.
- Fiorello Pharmaceuticals – manufacturing will take place in Schenectady County and dispensing facilities will be located in in Monroe, Nassau, New York and Saratoga Counties.
- New York Canna (d/b/a Terradiol New York) – manufacturing will be in Onondaga County and dispensing facilities will be locatedin Erie, Orange, Queens and Suffolk Counties. Terradiol unsuccessfully applied for a cultivation license in Pennsylvania, but it has also applied for a medical cannabis cultivation license in Ohio.
- PalliaTech NY – manufacturing will be based in Ulster County and dispensing facilities will be in Clinton, Nassau, Orange and Queens Counties.
- Valley Agriceuticals – manufacturing will take place in Orange County and dispensing facilities will be in Dutchess, Kings, Oneida and Suffolk Counties. According to the Marijuana Index, Valley Agriceuticals was acquired by iAnthus Capital (CSE:IAN)(OTCQB:ITHUF) this past June.
PalliaTech has a minority stake in one of Florida’s legal cultivators and has also applied for cultivation licenses in Ohio and Pennsylvania.
The five aforementioned licensees had previously ranked sixth through tenth in New York’s original application rankings from 2015, as reported by the Times Union.
The five companies that were awarded licenses in 2015 have faced numerous challenges, with Bloomfield Industries suffering financial constraints resulting in its acquisition by MedMen, a California-based turnkey cannabis management company, and four of the original five licensees attempted to sue the state to block the addition of registered organizations to no avail.